NCT03100825 - A Long-term Safety Study of QVM149 in Japanese Patients With Asthma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 28, 2017

Primary Completion Date

September 18, 2018

Study Completion Date

April 8, 2019

Conditions

Asthma

Interventions

DRUG

QVM149

QVM149 (indacaterol acetate/glycopyrronium bromide/mometasone furoate)

Trial Locations (25)

811 3195

Novartis Investigative Site, Koga

832-0059

Novartis Investigative Site, Yanagawa

371-0054

Novartis Investigative Site, Maebashi

732-0052

Novartis Investigative Site, Hiroshima

001-0901

Novartis Investigative Site, Sapporo

053-8506

Novartis Investigative Site, Tomakomai

761-8073

Novartis Investigative Site, Takamatsu

251-0041

Novartis Investigative Site, Fujisawa

228-8522

Novartis Investigative Site, Sagamihara

229-1103

Novartis Investigative Site, Sagamihara

236 0051

Novartis Investigative Site, Yokohama

510-8561

Novartis Investigative Site, Yokkaichi

940-2085

Novartis Investigative Site, Nagaoka

530 0001

Novartis Investigative Site, Osaka

591 8037

Novartis Investigative Site, Sakai

362-8588

Novartis Investigative Site, Ageo

104-0031

Novartis Investigative Site, Chuo Ku

103-0003

Novartis Investigative Site, Chuo-ku

103-0027

Novartis Investigative Site, Chuo-ku

103-0028

Novartis Investigative Site, Chuo-ku

145 0063

Novartis Investigative Site, Ōta-ku

158-0097

Novartis Investigative Site, Setagaya-ku

158-8531

Novartis Investigative Site, Setagaya-ku

142-8666

Novartis Investigative Site, Shinagawa-ku

170 0003

Novartis Investigative Site, Toshima Ku